Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

InspireMD (NSPR) EPS (Basic) (2016 - 2025)

InspireMD's EPS (Basic) history spans 16 years, with the latest figure at -$0.12 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 33.33% year-over-year to -$0.12; the TTM value through Dec 2025 reached -$0.77, changed 0.0%, while the annual FY2025 figure was -$0.76, 0.0% changed from the prior year.
  • EPS (Basic) reached -$0.12 in Q4 2025 per NSPR's latest filing, up from -$0.17 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.12 in Q4 2025 to a low of -$0.6 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$0.35, with a median of -$0.25 recorded in 2023.
  • Peak YoY movement for EPS (Basic): soared 91.74% in 2021, then plummeted 38.46% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.53 in 2021, then decreased by 13.21% to -$0.6 in 2022, then soared by 78.33% to -$0.13 in 2023, then crashed by 38.46% to -$0.18 in 2024, then surged by 33.33% to -$0.12 in 2025.
  • Per Business Quant, the three most recent readings for NSPR's EPS (Basic) are -$0.12 (Q4 2025), -$0.17 (Q3 2025), and -$0.26 (Q2 2025).